News | April 07, 2024
LANXESS showcases extensive portfolio for the cosmetics industry at in-cosmetics Global
Highly effective preservation solutions ensuring the safety and protection of personal care products
Highly effective preservation solutions ensuring the safety and protection of personal care products
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
To accelerate the development of next-generation radioconjugates to treat cancer
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Subscribe To Our Newsletter & Stay Updated
